Maarten A. Ligtenberg

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Dietary and lifestyle inflammation scores in relation to colon cancer recurrence in subgroups of patients based on common molecular tumour characteristics.

Dietary and lifestyle inflammation scores in relation to colon cancer recurrence in subgroups of patients based on common molecular tumour characteristics.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Cell-Based Immunization Combined with Single-Round Cell Panning Enables Discovery of PSMA-Targeting Nanobodies from Phage Display Libraries.

Cell-Based Immunization Combined with Single-Round Cell Panning Enables Discovery of PSMA-Targeting Nanobodies from Phage Display Libraries.

Journal: Biomolecules

Published: December 18, 2025

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

Journal: Journal for immunotherapy of cancer

Published: August 09, 2024

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.

Journal: Cancer cell

Published: July 07, 2023

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Journal: Nature communications

Published: February 07, 2023

MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance.

MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance.

Journal: Melanoma research

Published: December 22, 2022

Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.

Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.

Journal: Cancer communications (London, England)

Published: November 21, 2022

Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.

Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.

Journal: Cancer immunology research

Published: June 18, 2022

RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells.

RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells.

Journal: Cell reports. Medicine

Published: October 22, 2021

Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.

Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 29, 2020

Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.

Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.

Journal: Nature communications

Published: July 08, 2020

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.

Journal: Journal of translational medicine

Published: April 29, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026